Slander with no proof also requires a bending of ethics!
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-240
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.8¢ |
Change
0.008(0.77%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 96.5¢ | $881.1K | 904.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 30512 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 282609 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 22152 | 0.975 |
14 | 128157 | 0.970 |
17 | 139457 | 0.965 |
13 | 193561 | 0.960 |
7 | 521324 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 289178 | 22 |
0.985 | 127762 | 14 |
0.990 | 337215 | 13 |
1.000 | 85139 | 11 |
1.010 | 60000 | 1 |
Last trade - 10.57am 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online